Delcath Systems Inc DCTH
News
Delcath Systems Reports Second Quarter 2026 Results and Business Highlights
Delcath Systems to Participate at the Canaccord Genuity 46th Annual Growth Conference
Delcath Systems to Host Second Quarter 2026 Earnings Call
Delcath Systems, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Delcath Systems Announces First Patient Dosed in Phase 2 Clinical Trial of HEPZATO™ in Liver-Dominant Metastatic Breast Cancer